The analysis of overall survival rate also indicated that a high level of GOT1 expression was linked to poor survival rate in certain types of tumors, including thyroid carcinoma, breast invasive carcinoma and lung cancer (Fig. 6 f-h). This evidence concerns the gene GOT1 and thyroid gland carcinoma.